26. January 2018 2017 was a landmark year for the pharmaceutical industries in the US and Europe, with a sharp increase in the number of new molecular entities (NMEs) being…
04. January 2018
The year gone by saw the highest number of generic drug approvals by the US Food and Drug Administration (FDA), along with the most ever novel drugs (46); the most ever novel devices, and the…
01. November 2017 The FDA guidance on application of the Biopharmaceutics Classification System (BCS) for waiver of in-vivo bioequivalence (BE) studies was issued in August…
30. October 2017
Training Date: April 26th & 27th, 2018
Location: Courtyard Seattle Sea-Tac Area 16038 West Valley Highway Tukwila Washington 98188 USA
Length: 2 Days
Price:
Price: $1,295.00 (Seminar Fee for One…
28. April 2017 The EMA and US FDA say they agree on how pharmaceutical firms should include quality-by-design (QbD) elements in drug approval and manufacturing change…
14. February 2017 Abstract 5w?>The morbidity and mortality toll of pediatric cancer affects the public health of children worldwide, but despite the gains in the fight…
08. February 2017
FDA and USP Workshop on Standards for Pharmaceutical Products
February 27–28, 2017 USP Meetings Center, Rockville, MD USA
More Information and Registration
18. November 2016 The US FDA has almost cleared a backlog of 4000 excipient formulations in its Inactive Ingredient Database (IID) and wants drugmakers to help ensure…
26. October 2016 Chinese FDA (CFDA) Order 134 "Matters Concerning Bundling Review and Approval of Pharmaceutical Packaging Materials, Pharmaceutical Excipients and Drugs"…